trial · primary record
Psilocybin
Alzheimer's Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 200 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Determine whether psilocybin enhances neuroplasticity (Neuroplasticity Composite Score (NPCS)) |
| Registry ID | NCT07721467 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:30.383Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07721467
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.